🏆 Intero Biosystems Wins TechCrunch Disrupt 2026 Startup Battlefield! 🧬
What if scientists could test how drugs affect the human gut using miniature, lab-grown human intestinal tissue — before testing them in people?
That’s the technology behind Intero Biosystems, the winner of TechCrunch Disrupt 2026’s Startup Battlefield competition! 🚀
🧬 What does Intero Biosystems do?
Founded by Charlie Childs and Madeline Eiken, the Denver-based biotech startup develops human intestinal organoids — tiny, lab-grown tissues that mimic aspects of the human gut.
Its flagship product, GastroScreen, helps pharmaceutical, biotechnology, food, and chemical companies study how drugs and other compounds affect intestinal tissue.
🔬 Why does this matter?
Traditional drug development often relies on animal testing, but biological differences between animals and humans can make results difficult to translate.
Intero’s approach aims to provide researchers with a more human-relevant way to study intestinal responses and evaluate compounds earlier in development.
🏆 What did the team win?
🔹 The Startup Battlefield Cup
🔹 A $100,000 equity-free prize
🔹 Recognition on one of the startup ecosystem’s prominent stages
🌍 A bigger shift in biotech
Intero’s win highlights the growing interest in technologies that combine biology, engineering, and human-relevant testing methods.
Although organoids are not a complete replacement for clinical trials or every form of animal testing, they could become valuable tools in the drug-development process.
💡 The takeaway
The next breakthrough in technology doesn’t always come from a software app or an AI model. Sometimes, it comes from recreating a tiny part of the human body in a laboratory.
Congratulations to Intero Biosystems for turning an ambitious scientific idea into a Startup Battlefield-winning innovation! 🎉
🔗 Read more: https://techcrunch.com/2026/10/15/and-the-winner-of-startup-battlefield-at-disrupt-2026-is-intero-biosystems/
#InteroBiosystems #TechCrunchDisrupt #StartupBattlefield #Biotech #HealthcareInnovation #DrugDiscovery #Organoids #LifeSciences #Startups #Innovation